5 research outputs found

    Demographic, clinical and microbiological characteristics of <i>m.tb</i> culture positive and HIV-infected patients in the study population stratified by sputum smear microscopy and urine MTB/RIF results.

    No full text
    #<p>9 patients did not have data CD4 count data.</p>§<p>Includes the following <i>m.tb</i> culture positive samples: 7 blood cultures, 11 pleural fluid samples, 4 pericardial fluid samples, 3 ascitic fluid samples, 8 cerebrospinal fluid (CSF) samples, 1 hip biopsy, 2 Lymph node biopsies, 5 fine needle aspirate, 1 gastric washing, 1 faeces and 2 pus swabs.</p>†<p>P-values indicate significant differences between patient groups (marked with <sup>*</sup> to indicate comparison group) for demographic, clinical or microbiological characteristics.</p

    Diagnostic accuracy of sputum smear microscopy, urinary MTB/RIF, TB LAM ELISA, LAM strip test (grade 2 cut-point) and clinically relevant combinations thereof in any sputum/non-sputum <i>m.tb</i> culture positive patients overall, in sputum scarce patients only, and stratified by CD4 cell count<sup>†</sup>.

    No full text
    #<p>Indicates p<0.05 for a comparison of the sensitivity between different tests (e.g. urine MTB/RIF vs. LAM strip test) or combinations thereof; specific p-value: <sup>#1</sup>p = 0.002; <sup>#2</sup>p = 0.003; <sup>#3</sup>p = 0.001; <sup>#4</sup>p = 0.01; <sup>#5</sup>p = 0.06; <sup>#6</sup>p = 0.02; <sup>#7</sup>p = 0.05; <sup>#8</sup>p = 0.02; <sup>#9</sup>p<0.001; <sup>#10</sup>p = 0.002; <sup>#11</sup>p = 0.03.</p>*<p>Indicates p<0.05 for a comparison of differences in sensitivity between CD4>200 and ≤200 groups for a specific test or combinations thereof; specific p-values: <sup>*1</sup>p = 0.04;<sup> *2</sup>p<0.001; <sup>*3</sup>p = 0.009; <sup>*4</sup>p<0.001; <sup>*5</sup>p = 0.03; non-significant p-values not shown.</p>†<p>9 culture positive patients with no available CD4 cell count results.</p>§<p>Reference standard of culture was used which does not account for persons with culture-negative, clinical TB.</p

    Venn diagram showing the proportions of patients diagnosed by urine MTB/RIF and/or urine LAM ELISA in sputum scarce <i>m.tb</i> culture positive patients.

    No full text
    <p>6 patients were both urine MTB/RIF and LAM ELISA positive; 6 patients were urine LAM ELISA positive, but MTB/RIF negative, while 2 patients were urine MTB/RIF positive, LAM ELISA negative.</p

    Urine-based MTB/RIF-generated C<sub>T</sub> values correlates with other markers of bacillary burden.

    No full text
    <p>In <i>m.tb</i> culture and urine MTB/RIF positive patients, MTB/RIF-generated C<sub>T</sub> values were correlated with (A) urine LAM ELISA concentration, (B) urine LAM strip grading, (C) either sputum or non-sputum liquid culture time-to-positivity (TTP), (D) only sputum liquid culture time-to-positivity, and (E) smear-grade in smear positive patients.</p
    corecore